Company Overview and News

 
Controversial $150 million aged-care development gets green light

2017-12-31 smh.com.au
An Aveo retirement village at 24 Free Street, Newmarket, currently has 74 villas on the site but in 2016 the aged-care provider proposed to build almost 300 units in buildings up to seven storeys on the land.
Upvote Downvote

 
Brisbane aged care residents 'intimidated' by development proponents

2017-10-24 smh.com.au
A resident has pleaded with Brisbane City Council to stop an aged-care provider knocking down residents' villas to build hundreds of units at Newmarket.
Upvote Downvote

 
Love is in the air for Dr Jerry’s new Sofitel

2017-10-01 theage.com.au
When Dr Jerry Schwartz discovered a massive model of a heart in a Darling Harbour parking lot that he had just purchased, he knew it was an omen for his most expensive real estate deal to date – the Sofitel Sydney Darling Harbour – which launches on Tuesday.
Upvote Downvote

 
Love is in the air for Dr Jerry’s new Sofitel

2017-10-01 smh.com.au
When Dr Jerry Schwartz discovered a massive model of a heart in a Darling Harbour parking lot that he had just purchased, he knew it was an omen for his most expensive real estate deal to date – the Sofitel Sydney Darling Harbour – which launches on Tuesday.
Upvote Downvote

 
Meatpacker whacked by police

2017-09-13 perthnow.com.au
THE Australian market looks set to open flat after Wall Street’s key markets gave up early gains to close hardly changed albeit at record highs. At 0700 AEST on Thursday, the share price futures index was up one point, or 0.02 per cent, at 5,747.
Upvote Downvote

 
Finance news you need to know today

2017-08-16 perthnow.com.au
THE Australian share market looks set to open modestly higher, after Wall Street closed up despite its key indexes losing ground following President Donald Trump’s disbanding of two business councils in the wake of CEO defections. At 0700 AEST on Thursday, the share price futures index was up 12 points, or 0.21 per cent, at 5,758.
Upvote Downvote

 
Opportunities - and pitfalls - to investing in baby boomers' retirements: UBS

2017-07-13 theage.com.au
Within the next 15 years, almost all of the 6 million Australians who make up the 'baby boomer' generation will reach or be well into their retirement. The vast majority will not be wealthy enough to get by without an income unless they sell the equity in their home and move into some form of retirement accommodation. The sector is set to boom in coming years, and the small cap equities fund managers at UBS are already buying in.
Upvote Downvote

 
Opportunities - and pitfalls - to investing in baby boomers' retirements: UBS

2017-07-13 smh.com.au
Within the next 15 years, almost all of the 6 million Australians who make up the 'baby boomer' generation will reach or be well into their retirement. The vast majority will not be wealthy enough to get by without an income unless they sell the equity in their home and move into some form of retirement accommodation. The sector is set to boom in coming years, and the small cap equities fund managers at UBS are already buying in.
Upvote Downvote

 
Analysts and fund managers eye ASX reset in traditionally stronger July

2017-07-03 smh.com.au
After May's heavy selling and June's doldrums, analysts and fund managers believe ASX investors could see a reset in July.
Upvote Downvote

 
Analysts and fund managers eye ASX reset in traditionally stronger July

2017-07-03 theage.com.au
After May's heavy selling and June's doldrums, analysts and fund managers believe ASX investors could see a reset in July.
Upvote Downvote

 
'They are trapped': Retirees bought in, now they're fighting to save their villas

2017-06-29 smh.com.au
Aveo, the company that owns their Newmarket retirement complex in Free Street, wants to demolish the 74 ground-floor villas, and replace them with 300 units arranged in buildings up to seven storeys.
Upvote Downvote

 
Aveo my goodness - retirement company resists temptation

2017-06-28 theage.com.au
​The brains trust at Aveo Group have resisted the temptation just to batten down the hatches against the Fairfax Media/ABC allegations it is ripping off customers at its retirement villages, and ride out the storm.
Upvote Downvote

 
Aveo my goodness - retirement company resists temptation

2017-06-28 smh.com.au
​The brains trust at Aveo Group have resisted the temptation just to batten down the hatches against the Fairfax Media/ABC allegations it is ripping off customers at its retirement villages, and ride out the storm.
Upvote Downvote

 
Malaysian billionaire denies exploiting elderly in Aussie retirement home scandal

2017-06-28 themalaymailonline
A screenshot of billionaire Lee Seng Huang, who is the non-executive chairman of Aveo, Australia’s largest listed retirement village operator. ― Picture via Facebook/Four CornersKUALA LUMPUR, June 28 ― Aveo Group non-executive chairman Lee Seng Huang claimed to be a victim of sensationalised and biased reporting after Australian media accused his company of swindling elderly clients in its retirement villages in Australia.
Upvote Downvote

 
Breakfast briefing: Wednesday, June 28

2017-06-28 thestar.com.my
MarketWatch: The tech-heavy Nasdaq led a broad Wall Street decline on Tuesday with stocks falling more sharply after a healthcare bill was delayed in the US Senate, raising fresh questions about President Trump's domestic agenda. The DJIA fell 98.89 points, or 0.46%, to 21,310.66, the S&P 500 lost 19.69 points, or 0.81%, to 2,419.38 and the Nasdaq dropped 100.53 points, or 1.61%, to 6,146.62. - Reuters
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...